Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Endometrial Cancer

There is a consensus that adjuvant radiochemotherapy is needed for stage endometrial cancer, but the best modality of radiochemotherapy is still uncertain. The retrospective data of our center showed that the sequential radiochemotherapy of "chemotherapy-radiotherapy-chemotherapy" in the "sanwich" mode could improve the survival outcome in patients with advanced endometrial cancer.

stage iii endometrial cancer
adjuvant
hysterectomy
neutrophil count
endometrial carcinoma
  • 0 views
  • 05 Aug, 2020
Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus

Aim To investigate the effect of sentinel lymph node (SLN) sampling on the prognosis of patients with middle-high risk endometrial cancer obviously confined to the uterus before surgery.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

adjuvant
immunomodulators
immunomodulator
sarcoma
endometrial carcinoma
  • 0 views
  • 16 Feb, 2024
  • 95 locations
A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)

In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumors who have progressed on standard of care therapy will be treated with pembrolizumab (MK-3475).

  • 0 views
  • 20 Jul, 2022
  • 24 locations
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.

pleural effusions
x-rays
formalin-fixed paraffin-embedded
major surgery
endometrial carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer

The goal of this study is to evaluate short course radiation in the post-operative female pelvis after hysterectomy in stage III-IVA endometrial adenocarcinoma patients, or any stage patients with uterine serous or carcinosarcoma histology. The investigators hypothesize that short course pelvic radiation will have an acute and late grade 3-4 …

hysterectomy
neutrophil count
pelvic radiation
endometrial cancer
adenocarcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts. The four cancers type are NSCLC and melanoma that are progressing …

non-small cell lung cancer
monoclonal antibodies
systemic therapy
cemiplimab
hepatitis b antigen
  • 0 views
  • 16 Feb, 2024
  • 9 locations
The Application of Real-Time Near-infrared Imaging in Gynecological Surgery

Removing in situ and metastasis lesions completely during gynecological surgery is central to reduce the recurrence and death, and the identification of lesions in traditional gynecological surgery often depends on the experience of surgeons. The identification of nerves is often needed in gynecological surgery, such as the obturator nerves in …

gynecologic surgery
sarcoma
endometrial cancer
metastasis
adenomyosis
  • 0 views
  • 16 Feb, 2024
  • 1 location
Predictors of Recurrence for High Risk Endometrial Cancer Patients

This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.

cancer
immunomodulators
endometrial cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Staging Endometrial caNcer Based on molEcular ClAssification

The SENECA study tries to evaluate the rate of lymph node involvement depending on the molecular subgroup in early-stage endometrial cancer (I/II) patients undergoing surgery as part of their treatment.

Accepts healthy volunteers
  • 0 views
  • 01 Feb, 2023
  • 1 location